Trade SGP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
SpyGlass Pharma, Inc. (SGP) is trading at US$27.52, up 0.77% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$886.71M. Over the past 52 weeks, SGP has traded between US$16.00 and US$32.44. On Syfe you can trade SGP with $0 commission and add it to your watchlist.
| Previous close | US$27.31 |
|---|---|
| Market cap | US$886.71M |
| 52-week range | US$16.00 – US$32.44 |
| Volume | 169.47K |
| Exchange | US |
Add to Watchlist
Set Price Alert
SpyGlass Pharma, Inc.
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.
Year: 2026
Raymond James Initiates SpyGlass Pharma at Outperform, With $39 Price Target
Aug 14, 11:14 AM · MT Newswires
SpyGlass Pharma, Inc. (SGP) stock is trading at US$27.52, +0.77% from the previous close of US$27.31.
The market cap for SpyGlass Pharma, Inc. (SGP) stock is approximately US$886.71M.
The 52-week high for SpyGlass Pharma, Inc. (SGP) stock is US$32.44.
The 52-week low for SpyGlass Pharma, Inc. (SGP) stock is US$16.00.
SpyGlass Pharma, Inc. (SGP) does not currently pay a dividend.
Stay on top of SGP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
